A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

PHASE4CompletedINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

January 23, 2025

Study Completion Date

January 23, 2025

Conditions

Epilepsy

Interventions

DRUG

Perampanel

Perampanel tablets.

Trial Locations (10)

Eisai Site #9, Cheongju-si

Eisai Site #4, Daegu

Eisai Site #8, Daegu

Eisai Site #3, Daejeon

Eisai Site #10, Jeonju

Eisai Site #1, Seoul

Eisai Site #2, Seoul

Eisai Site #5, Seoul

Eisai Site #6, Seoul

Eisai Site #7, Seoul

All Listed Sponsors

lead

Eisai Korea Inc.

INDUSTRY